Articles

High plasma dopamine level as a risk factor for atopic dermatitis

Made Swastika Adiguna , Made Wardhana, Ermon Naftali Limbara

Made Swastika Adiguna
Dermatology and Venereology Departement, Faculty of Medicine, Universitas Udayana, Sanglah General Hospital Denpasar, Bali, Indonesia. Email: adiguna_bali@yahoo.co.id

Made Wardhana
Dermatology and Venereology Departement, Faculty of Medicine, Universitas Udayana, Sanglah General Hospital Denpasar, Bali, Indonesia

Ermon Naftali Limbara
Dermatology and Venereology Departement, Faculty of Medicine, Universitas Udayana, Sanglah General Hospital Denpasar, Bali, Indonesia Biomedical Master Science Study Program, Faculty of Medicine, Universitas Udayana
Online First: December 31, 2019 | Cite this Article
Adiguna, M., Wardhana, M., Limbara, E. 2019. High plasma dopamine level as a risk factor for atopic dermatitis. Bali Dermatology and Venereology Journal 2(1). DOI:10.15562/bdv.v2i1.15


Background: Dopamine is responsible for inflammatory response and plays a role in the skin immune system by modulating T-cells, dendritic cells, and keratinocytes which increases skin inflammatory response in atopic dermatitis (AD). Elevation of dopamine level will affect IL-6, IL-8, IL-23, Th-17, and TNF-α, which promotes keratinocyte proliferation and differentiation, infiltration of inflammatory cells, angiogenesis, vasodilation, and skin barrier disruption on AD.

Objective: This study aimed to establish whether the increase of plasma dopamine level contributes to a risk factor for AD occurrence.

Methods: This is a matched-pair case-control observational analytical study which involves patients with AD and without AD as control. Samples were taken using a consecutive sampling method which fulfilled inclusion and exclusion criteria, matched for gender and age. Plasma dopamine level was measured from venous blood and processed using enzyme-linked immunosorbent assay (ELISA) method. The collected data were then analysed using SPSS version 20.0 with Pearson chi-square test for the odds ratio.

Results: A total of 30 samples with AD (case group) and 30 samples without AD (control group) involved in this study. This study proves that plasma dopamine levels in the case group were significantly higher than the control group (p<0.05). Odds ratio for plasma dopamine was 42.2 (95%CI: 9.5-187.2, p < 0.001).

Conclusion: This study concludes that high plasma dopamine level is a risk factor for AD.

References

Schneider L, Tilles S, Lio P, Boguniewicz M, Beck L, Lebovidge J, Novak N. Atopic dermatitis: A practice parameter update 2012. J Allergy Clin Immunol. 2013;131:295-299.

Berke R, Singh A, Guralnick M. Atopic Dermatitis: An Overview. American Family Physician. 2012;86(1):35-42

Carson CG. Risk factors for developing atopic dermatitis. Dan Med J. 2013;60(7):1-24

Elias PM, Schmuth M. Abnormal Skin Barrier in the Etiopathogenesis of Atopic Dermatitis. Curr Opin Allergy Clin Immunol. 2009;9(5):437-446.

Wardhana M. Role of Environmental Allergens on Atopic Dermatitis. Bali Medical Journal. 2014;3(1):45-48

Lin TK, Zhong L, Santiago LJ. Association between stress and the HPA axis in the atopic dermatitis. Int J Mol.Sci. 2017;18:21-31.

Pacheco R, Contreras F, Zouali M. The dopaminergic system in autoimmune diseases. Frontiers in immunology. 2014;5:1-17.

Pacheco R, Prado CE, Barrientos MJ, Bernales S. Role of dopamine in the physiology of T-cells and dendritic cells. J Neuroimmunol. 2009;216:8-19.

Parrado AC, Canellada A, Gentile T, Rey-Roldan EB. Dopamine Agonist Upregulate IL-6 and IL-8 Production in Human Keratinocytes. Neuroimmunomodulation. 2012:19:359-366.

Wang X, Shii X, Feng L, Zhou P, Shen Y, Song Q. Prevalence and clinical features of adult atopic dermatitis in tertiary hospital of china. Medicine Journal. 2017;96:11.

Nicolae I, Ene CD, Schipor S, Tampa M, Matei C. Dopamine - Chemical Mediator in Atopic Dermatitis. REV CHIM. 2013;64(10):1201-1206.


Article Views      : 16
PDF Downloads : 7